Compugen Ltd (CGEN)
2.11
-0.03
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Compugen Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | 20.19M |
| June 30, 2021 | 13.44M |
| June 30, 2020 | -88.71M |
| June 30, 2019 | 8.658M |
| June 30, 2018 | -28.33M |
| June 30, 2017 | 22.32M |
| June 30, 2016 | 15.09M |
| June 30, 2015 | -3.618M |
| Date | Value |
|---|---|
| June 30, 2014 | 9.366M |
| June 30, 2013 | -10.46M |
| June 30, 2012 | 3.052M |
| June 30, 2011 | -3.075M |
| September 30, 2010 | -16.63M |
| June 30, 2010 | -9.321M |
| September 30, 2009 | 6.271M |
| June 30, 2009 | 6.253M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-88.71M
Minimum
Jun 2020
20.19M
Maximum
Jun 2022
-11.61M
Average
11.05M
Median
Cash from Investing (Quarterly) Benchmarks
| Pluri Inc | 5.668M |
| BioLine Rx Ltd | -20.40M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -0.006M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -34.02% |